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INTRODUCTION
The problem of hyperplastic processes of endometrium 
(HPE) occupies one of the main places in gynecological 
practice and constitutes (according to various sources) 
from 17% to 59% of the total gynecological pathology [10, 
11]. The interest in improving the diagnosis and treatment 
of benign hyperproliferative lesions of the uterus is not only 
necessary and expedient from the standpoint of oncological 
alertness, but also given the frequent recurrences of patho-
logical changes, reproductive disorders in this category of 
women, disorders of the ovarian-menstrual cycle and the 
development of chronic anemia.
Diagnostics of the endometrial polyps  (EP) does not 
cause any particular difficulties and has a clear algorithm 
of actions: visualization of formation, its evacuation fol-
lowed by histopathological studies (HS) to optimize the 
further tactics of the patient management [2]. At the same 
time, the curettage of the uterus and a “blind” biopsy are 
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ABSTRACT
The aim: To conduct a comparative analysis of the results of ultrasound and hysteroscopic examinations with further histopathological findings and the clinical and anamnestic 
features of patients with hyperproliferative pathology in order to determine the etiopathogenetic mechanisms of the development of endometrial pathological processes. 
Materials and methods: We studied 119 medical records of patients of the Gynecological Department of Minipal Non-Commercial Enterprise “Ternopil Municipal City Hospital 
No. 2”, who applied for medical assistance because of  benign endometrial hyperplasia in the reproductive age with a verified diagnosis of “uterine polyp” during 2017–2018. 
The control group consisted of 30 patients of the same age group, with menstrual disorders with no signs of hyperplastic processes of endometrium. With the consent of the 
patients, they were treated with diagnostic hysteroscopy in order to study evacuated material from the uterus. The results of the histological study confirmed the absence of 
signs of hyperplastic processes of endometrium. The results of diagnostic methods were evaluated by comparing the material’s histological data with the results of ultrasound 
and hysteroresectoscopy.
Results: Taking into account the results of our research, women with hyperplastic processes of endometrium have the risk of the pathology of the nervous system is in 2.71 times 
higher (OR=2.71, CI–0.88: 8.33), cardiovascular pathology—in 2.04 (OR=2.04, CI–0.57:7.34), vascular diseases of the lower extremities—in 1.81 times (OR=1.81, CI–0.21:15.32) 
compared with the control group. While the risk of pathology of the urinary system and organs of vision is only—OR=0.48, CI–0.11:2.03 and OR=0.75, CI–0.08:7.48, respectively.
Analyzing the results of the study using ultrasound examination, it was found that endometrial polyposis in combination with uterine leiomyoma was not detected in 3 women 
(15%), while all the results of hysteroscopy were confirmed by histopathological studies. When the endometrial hyperplastic processes were combined with adenomyosis—
according to ultrasound examination a false positive result was obtained in 2 patients (13.3%), and in a hysteroscopic study we determined –1 false positive result.
In patients the diagnosis of “endometrial polyp” according to the results of hysteroscopy was not confirmed in 2 women (2 false positive results 2.99%) and in 5 cases of ultrasound 
examination (5 false negative results 7.46%). The use of ultrasound examinations in patients with endometrial hyperplastic changes, according to our data, made it possible to 
identify pathology in 88.39% of cases, while the information content of the hysteroscopy was 98.21% (p<0.001). 
Conclusions: Thus, the results of the subjective examination of patients in the gynecological department: complaints, anamnestic data on gynecological and extragenital 
pathology should be used to identify etiopathogenetic factors and the formation of risk groups for the occurrence of hyperplastic processes of endometrium. Women with cervical 
erosion, uterine myoma and episodes of herpetic rash on the mucous membranes in past medical history have a higher likelihood of hyperplastic processes of endometrium.
The vast majority of patients (63.87%) with polyps of the body of the uterus have a combined hyperproliferative pathology, which requires an individual approach to planning 
the scope of diagnostic examination and the choice of treatment method. Visualization of endometrium with hysteroscopy is more informative than ultrasound for diagnosing 
hyperproliferative processes, including uterine polyps. Hysteroscopic polypectomy has a high level of both clinical and economic benefits as well as diagnostic value in patients 
with hyperplastic processes of endometrium.
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not the methods of choice today for diagnosing polyps 
of the uterus. When using this method, there is a risk of 
fragmentation of the polyp tissue, which often complicates 
the work of the histologist [3]. 
Today, the direct endoscopic visualization of the en-
dometrial cavity (hysteroscopy) is considered the “gold 
standard” in the diagnosis and treatment of polyps of the 
uterus body, and hysteroscopic polypectomy [4-6], which 
is deservedly called as “See–and–Treat” method [7]. Now-
adays, the method of hysteroscopy is widely used in many 
countries of the world, it is included in the standards of 
examination and treatment of patients with various gy-
necological pathologies. Analysis of the diagnostic value 
(sensitivity and specificity) of this method of examination 
and treatment of patients with various pathologies of the 
female reproductive system confirmed not only the diag-
nostic sensitivity, but also the economic feasibility of using 
hysteroscopy [1, 9].
In particular, the meta–analytical study that analyzed the 
hysteroscopic data of the main pathological changes in the 
endometrium in women with blood secretions from the 
genital tracts (based on Medline and the Cochrane Library 
data) revealed a high diagnostic accuracy of hysteroscopy 
for endometrial cancer, endometrial polyp and submucous 
leiomyoma [8].
Considering the above, to study the diversity of the 
clinical presentation of hyperproliferative pathology, we 
have analyzed and summarized the clinical and anamnestic 
data, parity, considered the accompanying pathology, and 
also analyzed the results of ultrasound and hysteroscopic 
examinations with further histopathological findings.
THE AIM
The aim to conduct a comparative analysis of the results of 
ultrasound and hysteroscopic examinations with further 
histopathological findings and the clinical and anamnestic 
features of patients with hyperproliferative pathology in 
order to determine the etiopathogenetic mechanisms of 
the development of endometrial pathological processes. 
MATERIALS AND METHODS
We studied 119 medical records of patients of the Gy-
necological Department of Minipal Non-Commercial 
Enterprise “Ternopil Municipal City Hospital No. 2”, who 
applied for medical assistance because of  benign endo-
metrial hyperplasia in the reproductive age with a verified 
diagnosis of “uterine polyp” during 2017–2018. The age 
of women ranged from 20 to 49 years (on average 34.52 ± 
2.51). The research group included patients with simple and 
complex non-atypical endometrial hyperplasia according 
to the classification of hyperproliferative processes of en-
dometrium (developed by the Subcommittee on Uterine 
Corpus  of the International Society of Gynecologists and 
Pathologists and approved by WHO, 1994). According to 
its data, hyperplastic processes of endometrium are divided 
into 5 groups: 
• simple non-atypical endometrial hyperplasia;
• complex non-atypical endometrial hyperplasia;
• simple atypical endometrial hyperplasia;
• complex atypical endometrial hyperplasia;
• adenocarcinoma
The study group did not include medical records of women 
with alimentary–constitutional obesity (BMI>30.0).
The control group consisted of 30 patients of the same 
age group, with menstrual disorders with no signs of HPE. 
With the consent of the patients, they were treated with 
diagnostic hysteroscopy in order to study evacuated ma-
terial from the uterus. The results of the histological study 
confirmed the absence of signs of HPE.
Ultrasound examination (US) was carried out on the 
device “Philips HD11 XE” with a 3.5 MHz convex sensor 
and a 7.5 MHz vaginal sensor. Sonographic studies were 
conducted in the proliferative (6–8 day) or secretory (20–22 
day) phases of the menstrual cycle. 
Hysteroscopy was performed in the operative room with 
intravenous anesthesia on hard fiber optics of Companies 
“KARL STORZ” from the 6th to the 11th day of the men-
strual cycle (with the menstrual cycle preserved). Taking into 
account the results of ultrasound and hysteroscopy data, a 
resectoscope was used to completely remove the hyperplastic 
cells of the uterus and the cervical canal with further follow-up 
examination. After complete removal of the pathologically 
altered endometrial tissue, the resulting material was sent 
for histological examination. The material was fixed in 10% 
buffered formalin solution. Histological examination of tis-
sues was performed by the standard method of serial sections 
(paraffin sections were stained with hematoxylin–eosin and 
according to Van Gieson). The findings on the histological 
types of hyperplasia and endometrial polyps were based on 
the WHO classification for endometrial pathology (2014).
The results of diagnostic methods were evaluated by 
comparing the material’s histological data with the results 
of ultrasound and hysteroresectoscopy.
All diagnostic and therapeutic manipulations were 
carried out after the written consent of the patients for 
examination and treatment in accordance with the protocol 
approved by the Committee on Bioethics (No. 53/June 03, 
2019). Consent for surgical treatment was obtained prior 
to treatment.
The obtained data was processed using standard sta-
tistical methods using HP PREMIER EXPERIENCE 
personal computer with program Microsoft Word 2010, 
the graphics were built using Microsoft Excel. Statistical 
processing was carried out by the program Statistika 10. 
For statistical processing, the qualitative and quantitative 
variables were determined. For qualitative data, a frequency 
analysis of the occurrence of signs was performed with the 
determination of the error of the mid and 95% confidence 
interval. The quantitative variables were checked for nor-
mal distribution using descriptive statistics of criteria of 
Kolmogorov–Smirnov. For risk assessment there were de-
termined the odds ratio, confidence intervals, relative risk, 
etiological factor of influence, absolute (directly associated 
risk), percentage of associated risk and population risk.
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RESULTS 
Analysis of the results of the subjective examination showed 
that the most frequent complaints when admission to hospital 
in patients with endometrial hyperproliferative processes were 
menstrual disorders—(27 women—28.57%), pain (25 pa-
tients—21.01 %%), frequent and significant menstruation (20 
patients— 16.81%), infertility in 11 cases (9.24%), 4 women 
felt general weakness (3.36%), a combination of complaints 
was found in 17 cases (14.29%), without special complaints 
were 8 women (6.72%) (p=0.01). The relative risk (RR) –OR 
was calculated—the occurrence of these complaints at ad-
mission to hospital of patients with HPE compared with the 
control group. Тhe above data are shown in table I. 
The maximum duration of this disease was 15 years, the 
minimum—2 weeks.
Fourty-forty patients (36.97%) received prior treatment 
for HPE: 10 women (8.40%) were prescribed hormone 
therapy, in 5 cases (4.20%) was used anti-inflammatory 
therapy. Firty percent of patients indicated on fractional 
therapeutic and diagnostic curettage (FTDC) in the past 
medical history: 17 women—once (14.29%), 5—two or 
more times (4.2%). Hormone therapy after FTDC received 
7 patients (22.73%) (p <0.005). 
Assessment of the relative risk of HPE taking into ac-
count the peculiarities of the gynecological past medical 
history. Тhe above data are shown in table II. 
When specifying the gynecological past medical history, 
cervical erosion was found in 70 women (62.2%), 40 pa-
tients (35.5%) suffered from chronic inflammatory diseases 
of the uterine appendages, 21 women (18.4%) reported 
uterine myoma, ovarian cysts were diagnosed in 11 patients 
(9.6%), 4 women (3.8%) noted polyps of the cervical canal 
in their past medical history, 2 women (1.8%) had ectopic 
pregnancies. Breast pathology was documented in 11 medi-
cal records (9.6%), in addition there were periodic herpetic 
rash on the mucous membranes—52 (43.70%) (p <0.005). 
Combined pathology was observed in 49 women (41.18%).
A detailed study of reproductive function showed that 22 
women had 1 birth in their past medical history (18.49%), 
32 gave birth 2 times or more (26.89%). Women who did 
not give birth amounted 48.74% (58 patients). Twenty-six 
and six hundredths percent of patients had abortions in 
their anamnesis, among them 1 abortion—16 women 
(13.45%), 2 or more—15 (12.61%), and 81 women had no 
abortions in their anamnesis (68.07%). For the purpose of 
contraception, 19 patients (11.9%) had IUDs, 9 patients 
used hormonal contraceptives (7.56%) (p <0.005). 
An extragenital pathology was detected in 74 patients 
(64.18%), of which 25.21% was combined (p<0.005). The 
structure of associated diseases revealed: changes in the 
cardiovascular system in 18.49% of patients, diseases of 
the nervous system in 29.41%, pathology of the gastroin-
Table I. Relative risk of complaints in patients with hyperplastic processes of endometrium
No. Complaints OR
Confidence interval
lower bound upper bound
1 disorder of the menstrual cycle 0,8 0,34 1,88
2 Pain 2,39 0,67 8,53
3 frequent and significant menstruation 1,31 0,41 4,18
4 Infertility 0,66 0,20 2,25
5 general weakness 1,01 0,10 9,40
6 combination of women’s complaints 1,5 0,41 5,50
7 without significant complaints 0,36 0,11 1,19
Level of significance λ (alpha)=0.05
Table II. The relative risk of hyperplastic processes of endometrium in patients with concomitant gynecological pathology
No. Gynecological anamnesis OR
Confidence interval
lower bound upper bound
1 erosion of the cervix 5,71 2,17 15,02
2 ovarian cysts 2,95 0,37 23,83
3 chronic inflammatory diseases of the uterine appendages 3,29 1,07 10,08
4 ectopic pregnancy 0,50 0,04 5,66
5 mammary pathology 1,43 0,30 6,81
6 polyps of the cervical canal 1,01 0,11 9,37
7 myoma of the uterus 6,21 0,8 48,19
8 herpetic rash on mucous membranes 5,05 1,66 15,36
9 combined pathology 9,8 2,23 43,06
Level of significance λ (alpha) = 0.05
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testinal tract—15.97%, diseases of the urinary–excretory 
system—5.04%, respiratory systems—8.40%, endocr-
inopathy— 29.41%, varicose disease of the lower extrem-
ities—5.88%, ophthalmic pathology— 2.52%.
A comparative analysis of the presence of extragenital 
pathology with the risk assessment in women with HPE 
in different systems of the body was conducted. Тhe above 
data are shown in table III.
According to the results of the conducted clinical lab-
oratory research, the most commonly diagnosed isolated 
pathology of endometrium was a polyp (56.30), while 
in 31 women (26.05%) polyps were detected not only in 
the  uterine cavity, but also in the cervical canal. In 20 cases 
(16.81%), the uterine polyp was combined with hyperpro-
liferative uterine disease—leiomyoma. The combination 
of the uterine polyp with adenomyosis was detected in 15 
patients (12.61%). A leiomyoma with adenomyosis was 
diagnosed with the uterine polyp in 10 patients (8.40%). 
During the study of the structure of hyperproliferative 
pathology in these patients there was revealed a combined 
pathology of myo- and endometrium. Тhe above data are 
shown in Figure 1.
A comparative assessment of the informativeness of ultra-
sound and hysteroscopy with the final results of a histopatho-
logical study in the diagnosis of endometrial hyperplasia was 
carried out. Тhe above data are shown in table IV. 
The analysis of the results of subjective examination of 
patients with HPE showed frequent pain syndrome in 
comparison with the control group in 2.71 times (OR=2.71, 
CI–0.88:8.33). At the same time, patients with HPE often 
had complains on frequent and heavy menstruation, a 
general weakness in 1.31 (OR=1.31, CI–0.41: 4.18) and 
1.01 (OR=1.01, CI–0, 10:9.40) times, respectively. While 
complaints on infertility and menstrual dysfunction have 
no significant relative risk values: OR=0.66, CI–0.20:2.25 
and OR=0.8 CI–0.34:1.88, respectively.
Fig 1. Structure of hyperproliferative pathology of myometrium and 
endometrium
Table III. Risk assessment for body systems in women with hyperplastic processes of endometrium compared with the control group.






1 diseases of cardiovascular system 22 2,04 0,57 7,34
2 diseases of the nervous system 35 2,71 0,88 8,33
3 pathology of the gastrointestinal tract 19 1,24 0,39 3,94
4 diseases of the urinary excretory system 6 0,48 0,11 2,03
5 diseases of respiratory system 10 1,28 0,27 6,20
6 еndocrinopathy 24 1,01 0,37 2,75
7 varicose disease of the lower extremities 7 1,81 0,21 15,32
8 ophthalmic pathology 3 0,75 0,075 7,48
9 combined pathology 30 2,19 0,71 6,79
Level of significance λ (alpha) = 0.05
Table IV. Structure of detected pathology of endometrium by ultrasound, hysteroscopic examination and HS.




Polyposis of endometrium with leiomyoma of the uterus 163—false negative 20 20
Polyposis of endometrium with adenomyosis 182—false positive
16
1—false positive 15
Polyposis of endometrium with leiomyoma of the uterus and 
adenomyosis
13
3—false positive 10 10
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Taking into account these complaints, it is noteworthy 
that women with HPE have an increase in pain in 2.39 
(OR=2.71, CI–0.88:8.33) times higher in comparison with 
healthy patients.
Analysis of the results of the gynecological anamnesis 
showed that the relative risk of HPE in patients with 
cervical erosion is 5.71, chronic inflammatory diseases 
of the uterine appendages—3.29, uterine myoma—6.21, 
ovarian cysts—2.95, polyps of the cervical canal—1,01, 
ectopic pregnancies—0.50, breast pathology—1.43 (Table 
2). Thus, women with cervical erosion and uterine myoma 
have the risk of HPE respectively in 5.71 times (OR=5.71, 
CI–2.17:15.02) and 6.21 times (OR=6.21, CI–2.17:15.02) 
higher than in the control group. Interesting was the fact 
that the increase in the probability of the occurrence of 
HPE in women with past herpetic rash on the mucous 
membranes was by 5.05 times (OR=5.05, CI–1.66:15.36). 
Whereas the confidence interval in women, who had 
ectopic pregnancies in their anamnesis, does not have a 
significant difference (OR = 0.5, DI-0.04:5.66)
Thus, anamnestic data on cervical erosion, uterine 
myoma and episodes of herpetic rash on the mucous 
membranes can be assessed as specific and used to form 
risk groups.
Taking into account the results of our research, women 
with HPE have the risk of the pathology of the nervous sys-
tem is in 2.71 times higher (OR=2.71, CI–0.88: 8.33), car-
diovascular pathology—in 2.04 (OR=2.04, CI–0.57:7.34), 
vascular diseases of the lower extremities—in 1.81 times 
(OR=1.81, CI–0.21:15.32) compared with the control 
group. While the risk of pathology of the urinary system 
and organs of vision is only—OR=0.48, CI–0.11:2.03 and 
OR=0.75, CI–0.08:7.48, respectively.
Thus, the results of the evaluation of premorbid condi-
tions in patients with HPE require timely diagnostic and 
medical–preventive activities regarding the occurrence of 
this pathology.
DISCUSSION
The results of the conducted analysis indicate a significant 
percentage of patients with combined endometrial pathol-
ogy, which indicates the need to conduct a more detailed 
and in–depth study of the state of endo– and myometrium 
when uterine body polyps are detected using not only 
sufficiently informative, but also economically grounded 
diagnostic methods. These results are obviously crucial 
for the choice of treatment tactics. Frequent concomitant 
extragenital diseases necessitate an individual approach, 
both in the choice of adequate diagnostic methods and in 
effective treatment tactics.
Analyzing the results of the study using ultrasound 
examination, it was found that endometrial polyposis in 
combination with uterine leiomyoma was not detected in 
3 women (15%), while all the results of hysteroscopy were 
confirmed by HS. When the endometrial hyperplastic 
processes were combined with adenomyosis—according 
to ultrasound examination a false positive result was ob-
tained in 2 patients (13.3%), and in a hysteroscopic study 
we determined –1 false positive result.
In patients the diagnosis of “endometrial polyp” accord-
ing to the results of hysteroscopy was not confirmed in 2 
women (2 false positive results 2.99%) and in 5 cases of ul-
trasound examination (5 false negative results 7.46%). The 
clinical diagnosis in these patients was verified using HS.
The use of ultrasound examinations in patients with 
endometrial hyperplastic changes, according to our data, 
made it possible to identify pathology in 88.39% of cases, 
while the information content of the hysteroscopy was 
98.21% (p<0.001). The results of the study confirm the 
opinion about the need to use the possibilities of ultra-
sound and hysteroscopic examinations as complementary 
methods for the diagnosis of endometrial hyperplastic 
processes. At the same time, the data obtained by us testify 
the advantages of visualization of endometrial polyps in 
a gynecological department of hospital in favor of a hys-
teroscopic examination.
Considering our findings, it can be said that visualiza-
tion of polyps of the uterus with hysteroscopy is indeed a 
more informative diagnostic method and should be widely 
introduced into the clinical practice of treating women of 
reproductive age with endometrial hyperplastic processes 
in gynecological departments of hospitals.
CONCLUSIONS
Thus, the results of the subjective examination of patients 
in the gynecological department: complaints, anamnestic 
data on gynecological and extragenital pathology should be 
used to identify etiopathogenetic factors and the formation 
of risk groups for the occurrence of hyperplastic processes 
of endometrium.
Women with cervical erosion, uterine myoma and epi-
sodes of herpetic rash on the mucous membranes in past 
medical history have a higher likelihood of HPE.
The vast majority of patients (63.87%) with polyps of 
the body of the uterus have a combined hyperproliferative 
pathology, which requires an individual approach to plan-
ning the scope of diagnostic examination and the choice 
of treatment method.
Visualization of endometrium with hysteroscopy is more 
informative than ultrasound for diagnosing hyperprolifer-
ative processes, including uterine polyps.
Hysteroscopic polypectomy has a high level of both 
clinical and economic benefits as well as diagnostic value 
in patients with HPE.
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